Effectiveness and immunogenicity of respiratory syncytial virus vaccine (RSVpreF from Pfizer) for pregnant persons: A living systematic review and meta-analysis

Data sources

• Data source(s):
  Other data source
• Data source(s), other:
  Cochrane Library databases, ; MEDLINE, EMBASE, ; Latin American and Caribbean Health Sciences Literature (LILACS), ; Science Citation Index Expanded (SCI-EXPANDED), ; China Network Knowledge Information (CNKI), ; Chinese Biomedical Literature Database (CBM), ; Chinese Science Journal Database (CSDC), ; Grey literature published by national health agencies (e.g., US CDC, UKHSA) since August 2023 (date of RSVpreF maternal vaccine approval by the FDA) will also be included as data sources.
• Data sources (types):
  Published literature

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  Unknown